Buckle's low P/E ratio is due to its shrinking earnings outlook. Shareholders accept this as they anticipate no pleasant surprises in future earnings. These conditions may continue to limit the share price.
Insider selling at Buckle, Inc., including a significant sale by the Senior VP of Leasing, may worry investors. However, insiders owning a large part of the company could be positive. The absence of insider buying recently and ongoing selling is disconcerting.
Despite the company's current undervaluation, the prospect of negative growth introduces a degree of risk. Investors are advised to consider this risk before deciding to increase their portfolio exposure to BKE or diversify into another stock.
Given Buckle's increasing ROCE and its success in realizing profit from its capital, the company could have a potent future if it can continue these positive trends.
Multiple insiders selling shares over the past year could be a red flag. While there was some insider buying, the lack of substantial purchases prevents strong confidence. High insider ownership suggests the company is run for all shareholders, but increased buying would boost confidence in Buckle insider transactions.
Buckle's bargain potential poses risk due to possible negative earnings growth, say analysts. Investors advised to probe Buckle further and current shareholders to consider portfolio exposure.
Buckle Inc Stock Forum
The price has gone up a bit since I’ve first bought, but this is a high quality stock
In reaction to earnings/guidance:
• $Foot Locker (FL.US)$ +19.7%, $BILL Holdings (BILL.US)$ +18.1% (also names new COO), $Buckle Inc (BKE.US)$ +1.7%
Other news:
• $Axsome Therapeutics (AXSM.US)$ +33.8% (announces FDA approval of AUVELITY the first and only oral nmda receptor antagonist for the treatment of major depressive disorder in adults)
• $SpringWorks Therapeutics (SWTX.US)$ +4.9% (late-breaking oral presentation of phase 3 DeFi da...
No comment yet